Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] -  Global Trends & Competitive Analysis to 2017
Upcoming SlideShare
Loading in...5
×
 

Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] - Global Trends & Competitive Analysis to 2017

on

  • 279 views

 

Statistics

Views

Total Views
279
Views on SlideShare
279
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] -  Global Trends & Competitive Analysis to 2017 Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] - Global Trends & Competitive Analysis to 2017 Document Transcript

  • Neurovascular/Interventional Neurology Market [AneurysmCoils, Carotid Stents, Microcatheter, Microguidewire, LiquidEmbolic Agents, & Cerebral Angioplasty Balloons] - GlobalTrends & Competitive Analysis to 2017Report Details:Published:October 2012No. of Pages: 234Price: Single User License – US$4650Neurointerventional radiology or endovascular neurosurgery refers to special minimally invasiveprocedures to diagnose and treat vascular disorders of the brain and spine. With the help ofadvanced imaging for guidance, neurointerventionalists or neurosurgeons use microcatheters (tinytubes) to treat many complex disorders. Normally these disorders are treated either by closing(embolization) or opening (recanalization) the abnormal vessels. The neurointerventional devicemarket encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, andsnare device), cerebral angiography and stenting system (carotid stent, and embolic protectionsystem), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device)and support devices (microcatheter, and microguidewire).The neurointerventional devices market encompasses neurothrombectomy devices(suction/aspiration device, clot retriever, and snare device), cerebral angiography and stentingsystem (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil,liquid embolic agents, and flow diversion device) and support devices (microcatheter, andmicroguidewire).The global neurointerventional devices market is estimated to be $1,248.5 million in 2012 and isexpected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017. Aneurysm Coiling &Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largestshare of the global neurointerventional devices market, followed by support devices cerebralballoon angioplasty & stenting systems and neurothrombectomy devices in 2012.The major driving factor for these markets involves gradual technological evolution, growingageing and obese population, rising patient pool for ischemic and hemorrhagic stroke andincreasing demand for minimally invasive surgical procedures. Growing GDP and healthcareallocation are making developing countries in Asia and Latin America affordable to adapt novel
  • medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoringthe interventional procedure over neurosurgery as it offers limited hospital stays, minimal damageto surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimumsurgical trauma and lesser surgical scar.North America dominates the overall neurointerventional devices market. Asia-Pacific marketincluding India, China and Japan, and Latin America market are expected to grow at a higher pacedue to the effect of growing GDP and purchasing capability of healthcare institutions in thosecountries. Coiling procedure and flow diversion have gained popularity in the Asia-Pacific andLatin American market.The major players operating in the market are Covidien, PLC (Ireland), Stryker Corporation (U.S.),Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).Scope of the ReportThis research report categorizes the neurointerventional device market for devices used inneurothrombectomy procedure, cerebral angiography and stenting technique, aneurysm coilingprocedure and support devices.Various neurointerventional devices are categorized into:•Neurothrombectomy procedure - Suction/aspiration device, clot retriever, and snare device•Cerebral angiography and stenting technique - Carotid stent, and embolic protection system•Aneurysm coiling procedure – Platinum coil (Bare & Coated), Liquid embolic agents, and Flow diversion device.•Support devices - Microcatheter and MicroguidewireGet your copy of this report @http://www.reportsnreports.com/reports/203750-neurovascular-interventional-neurology-market-aneurysm-coils-carotid-stents-microcatheter-microguidewire-liquid-embolic-agents-cerebral-angioplasty-balloons-global-trends-competitive-analysis-to-2017.htmlMajor points covered in Table of Contents of this report includeTable Of Contents1 INTRODUCTION1.1 KEY TAKE-AWAYS1.2 REPORT DESCRIPTION1.3 MARKETS COVERED1.4 STAKEHOLDERS1.5 RESEARCH METHODOLOGY1.5.1 MARKET SIZE1.5.2 MARKET SHARE1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
  • 1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES1.5.5 ASSUMPTIONS2 EXECUTIVE SUMMARY3 MARKET OVERVIEW3.1 INTRODUCTION3.2 MARKET SEGMENTATION3.3 MARKET DYNAMICS3.3.1 DRIVERS3.3.1.1 Advancements in technology3.3.1.2 Increasing aging & obese population3.3.1.3 Increasing number of ischemic & hemorrhagic stroke patients3.3.1.4 Growing demand for minimally invasive surgery3.3.2 RESTRAINTS3.3.2.1 Increasing complexity in clinical trials3.3.2.2 Decreasing average selling prices3.3.2.3 Hospital budget constraints& alternative treatment facilities3.3.3 THREATS & OPPORTUNITIES3.4 TRENDS3.5 UPCOMING TECHNOLOGIES3.6 MARKET SHARE ANALYSIS4 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY TECHNIQUES4.1 INTRODUCTION4.2 NEUROTHROMBECTOMY4.3 CAROTID ARTERY ANGIOGRAPHY & STENTING4.4 EMBOLIZATION OF ARTERIOVENOUS MALFORMATION ARTERIOVENOUS FISTULA4.5 COILING PROCEDURE5 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCTS5.1 NEUROTHROMBECTOMY DEVICES5.1.1 INTRODUCTION5.1.2 SUCTION/ASPIRATION DEVICES5.1.3 CLOT RETRIEVER5.1.4 SNARE5.2 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS5.2.1 INTRODUCTION5.2.2 CAROTID ARTERY STENTS5.2.3 EMBOLIC PROTECTION SYSTEMS5.2.3.1 Distal filter devices5.2.3.2 Balloon occlusion devices
  • 5.3 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULAEMBOLIZATION5.3.1 INTRODUCTION5.3.2 EMBOLIC COIL5.3.2.1 Bare Platinum Detachable Coil5.3.2.2 Coated Detachable Coil5.3.3 LIQUID EMBOLIC AGENTS5.3.4 FLOW DIVERSION DEVICE5.4 SUPPORT DEVICES5.4.1 INTRODUCTION5.4.2 MICROCATHETER5.4.3 MICROGUIDEWIRE6 GEOGRAPHIC ANALYSIS6.1 INTRODUCTION6.2 NORTH AMERICA6.3 EUROPE6.4 ASIA6.5 REST OF THE WORLD (ROW)7 COMPETITIVE LANDSCAPE7.1 MERGERS & ACQUISITIONS7.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES7.3 NEW PRODUCT LAUNCH7.4 APPROVAL7.5 EXPANSION7.6 OTHER DEVELOPMENTS8 COMPANY PROFILES8.1 ABBOTT LABORATORIES8.1.1 OVERVIEW8.1.2 FINANCIALS8.1.3 PRODUCTS & SERVICES8.1.4 STRATEGY8.1.5 DEVELOPMENTS8.2 BAYER AG8.2.1 OVERVIEW8.2.2 FINANCIAL8.2.3 PRODUCTS & SERVICES8.2.4 STRATEGY8.2.5 DEVELOPMENTS8.3 COAXIA, INC.
  • 8.3.1 OVERVIEW8.3.2 FINANCIALS8.3.3 PRODUCTS & SERVICES8.3.4 STRATEGY8.3.5 DEVELOPMENTS8.4 COVIDIEN, PLC8.4.1 OVERVIEW8.4.2 FINANCIALS8.4.3 PRODUCTS & SERVICES8.4.4 STRATEGY8.4.5 DEVELOPMENTS8.5 JOHNSON & JOHNSON8.5.1 OVERVIEW8.5.2 FINANCIALS8.5.3 PRODUCTS & SERVICES8.5.4 STRATEGY8.5.5 DEVELOPMENTS8.6 MERIT MEDICAL SYSTEMS, INC.8.6.1 OVERVIEW8.6.2 FINANCIALS8.6.3 PRODUCTS & SERVICES8.6.4 STRATEGY8.6.5 DEVELOPMENTS8.7 NEUROINTERVENTIONAL THERAPEUTICS, INC. (NIT)8.7.1 OVERVIEW8.7.2 FINANCIALS8.7.3 PRODUCTS & SERVICES8.7.4 STRATEGY8.7.5 DEVELOPMENTS8.8 NFOCUS NEUROMEDICAL, INC.8.8.1 OVERVIEW8.8.2 FINANCIALS8.8.3 PRODUCTS & SERVICES8.8.4 STRATEGY8.8.5 DEVELOPMENTS8.9 PENUMBRA, INC.8.9.1 OVERVIEW8.9.2 FINANCIALS8.9.3 PRODUCTS & SERVICES8.9.4 STRATEGY8.9.5 DEVELOPMENTS8.10 REVERSE MEDICAL CORPORATION
  • 8.10.1 OVERVIEW8.10.2 FINANCIALS8.10.3 PRODUCTS & SERVICES8.10.4 STRATEGY8.10.5 DEVELOPMENTS8.11 STRYKER CORPORATION8.11.1 OVERVIEW8.11.2 FINANCIALS8.11.3 PRODUCTS & SERVICES8.11.4 STRATEGY8.11.5 DEVELOPMENTS8.12 TERUMO CORPORATION8.12.1 OVERVIEW8.12.2 FINANCIALS8.12.3 PRODUCTS & SERVICES8.12.4 STRATEGY8.12.5 DEVELOPMENTS8.13 VALOR MEDICAL, INC.8.13.1 OVERVIEW8.13.2 FINANCIALS8.13.3 PRODUCTS & SERVICES8.13.4 STRATEGY8.13.5 DEVELOPMENTS8.14 W.L.GORE & ASSOCIATES, INC.8.14.1 OVERVIEW8.14.2 FINANCIALS8.14.3 PRODUCTS & SERVICES8.14.4 STRATEGY8.14.5 DEVELOPMENTSList Of TablesTABLE 1 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)TABLE 2 UPCOMING TECHNOLOGY: PHASE IV CLINICAL TRIAL STUDYTABLE 3 UPCOMING TECHNOLOGY: PHASE III CLINICAL TRIAL STUDYTABLE 4 UPCOMING TECHNOLOGY: PHASE II CLINICAL TRIAL STUDYTABLE 5 UPCOMING TECHNOLOGY: PHASE I CLINICAL TRIAL STUDYTABLE 6 UPCOMING TECHNOLOGY: 510 (K) APPROVALTABLE 7 UPCOMING TECHNOLOGY: OTHERS CLINICAL TRIAL STUDYTABLE 8 NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 –2017 ($MILLION)
  • TABLE 9 GLOBAL NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)TABLE 10 NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 –2017 ($MILLION)TABLE 11 GLOBAL CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKETREVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)TABLE 12 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKETREVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 13 GLOBAL ANEURYSM COILING & ARTERIOVENOUS MALFORMATIONEMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 14 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION &FISTULA EMBOLIZATION MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 15 SUCTION/ASPIRATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 –2017 ($MILLION)TABLE 16 SUCTION/ASPIRATION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 –2017 (NO. OF UNITS)TABLE 17 CLOT RETRIEVER MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 18 CLOT RETRIEVER MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OFUNITS)TABLE 19 SNARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 20 SNARE DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OFUNITS)TABLE 21 CAROTID ARTERY STENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 22 CAROTID ARTERY STENTS MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017(NO. OF UNITS)TABLE 23 EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 24 EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 –2017 ($MILLION)TABLE 25 DISTAL FILTER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 26 DISTAL FILTER DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO.OF UNITS)TABLE 27 BALLOON OCCLUSION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 –2017 ($MILLION)TABLE 28 BALLOON OCCLUSION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 –2017 (NO. OF UNITS)TABLE 29 GLOBAL EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 30 EMBOLIC COIL MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
  • TABLE 31 EMBOLIC COIL MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)TABLE 32 BARE PLATINUM DETACHABLE COIL MARKET REVENUE, BY GEOGRAPHY, 2010– 2017 ($MILLION)TABLE 33 BARE PLATINUM DETACHABLE COIL MARKET VOLUME, BY GEOGRAPHY, 2010– 2017 (NO. OF UNITS)TABLE 34 COATED DETACHABLE COIL MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 35 COATED DETACHABLE COIL MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017(NO. OF UNITS)TABLE 36 LIQUID EMBOLIC AGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 37 LIQUID EMBOLIC AGENTS MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO.OF UNITS)TABLE 38 FLOW DIVERSION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 39 FLOW DIVERSION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017(NO. OF UNITS)TABLE 40 GLOBAL SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 41 SUPPORT DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 42 MICROCATHETERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 43 MICROCATHETERS MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OFUNITS)TABLE 44 MICROGUIDEWIRES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 45 MICROGUIDEWIRES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OFUNITS)TABLE 46 NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 –2017 ($MILLION)TABLE 47 NORTH AMERICA: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BYPRODUCTS, 2010 – 2017 ($MILLION)TABLE 48 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BYPRODUCTS, 2010 – 2017 ($MILLION)TABLE 49 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BYPRODUCTS, 2010 – 2017 (NO. OF UNITS)TABLE 50 NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMSMARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)TABLE 51 NORTH AMERICA: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BYPRODUCTS, 2010 – 2017 ($MILLION)TABLE 52 NORTH AMERICA: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY
  • PRODUCTS, 2010 – 2017 (NO. OF UNITS)TABLE 53 NORTH AMERICA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATIONEMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 54 NORTH AMERICA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATIONEMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 – 2017(NO. OF UNITS)TABLE 55 NORTH AMERICA: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 56 NORTH AMERICA: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 –2017 (NO. OF UNITS)TABLE 57 NORTH AMERICA: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010– 2017 ($MILLION)TABLE 58 NORTH AMERICA: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010– 2017 (NO. OF UNITS)TABLE 59 EUROPE: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BYPRODUCTS, 2010 – 2017 ($MILLION)TABLE 60 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BYPRODUCTS, 2010 – 2017 ($MILLION)TABLE 61 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS,2010 – 2017 (NO. OF UNITS)TABLE 62 EUROPE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKETREVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)TABLE 63 EUROPE: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BYPRODUCTS, 2010 – 2017 ($MILLION)TABLE 64 EUROPE: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS,2010 – 2017 (NO. OF UNITS)TABLE 65 EUROPE: ANEURYSM COILING & ARTERIOVENOUS MALFORMATIONEMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 66 EUROPE: ANEURYSM COILING & ARTERIOVENOUS MALFORMATIONEMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 – 2017(NO. OF UNITS)TABLE 67 EUROPE: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 68 EUROPE: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO.OF UNITS)TABLE 69 EUROPE: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 70 EUROPE: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017(NO. OF UNITS)TABLE 71 ASIA: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS,
  • 2010 – 2017 ($MILLION)TABLE 72 ASIA: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)TABLE 73 ASIA: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS,2010 – 2017 (NO. OF UNITS)TABLE 74 ASIA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKETREVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)TABLE 75 ASIA: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)TABLE 76 ASIA: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010– 2017 (NO. OF UNITS)TABLE 77 ASIA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATIONEMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 78 ASIA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATIONEMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 – 2017(NO. OF UNITS)TABLE 79 ASIA: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 80 ASIA: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OFUNITS)TABLE 81 ASIA: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 82 ASIA: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO.OF UNITS)TABLE 83 ROW: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)TABLE 84 ROW: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)TABLE 85 ROW: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS,2010 – 2017 (NO. OF UNITS)TABLE 86 ROW: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKETREVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)TABLE 87 ROW: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)TABLE 88 ROW: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS,2010 – 2017 (NO. OF UNITS)TABLE 89 ROW: ANEURYSM COILING & ARTERIOVENOUS MALFORMATIONEMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 90 ROW: ANEURYSM COILING & ARTERIOVENOUS MALFORMATIONEMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 – 2017
  • (NO. OF UNITS)TABLE 91 ROW: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 92 ROW: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OFUNITS)TABLE 93 ROW: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 94 ROW: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO.OF UNITS)TABLE 95 MERGERS & ACQUISITIONS, 2009 – 2012TABLE 96 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, 2009 –2012TABLE 97 NEW PRODUCT LAUNCH, 2009 – 2012TABLE 98 APPROVAL, 2009 – 2012TABLE 99 EXPANSION, 2009 – 2012TABLE 100 OTHER DEVELOPMENTS, 2009 – 2012TABLE 101 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011($MILLION)TABLE 102 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011($MILLION)TABLE 103 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011($MILLION)TABLE 104 BAYER AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)TABLE 105 BAYER AG: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)TABLE 106 BAYER AG: HEALTHCARE TOTAL REVENUE, BY DIVISIONS, 2009 – 2011($MILLION)TABLE 107 BAYER AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)TABLE 108 BAYER AG: TOTAL REVENUE OF HEALTHCARE DIVISION, BY GEOGRAPHY,2009 – 2011 ($MILLION)TABLE 109 COVIDIEN, PLC : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011($MILLION)TABLE 110 COVIDIEN, PLC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)TABLE 111 COVIDIEN, PLC: MEDICAL DEVICES TOTAL REVENUE, BY SEGMENTS, 2009 –2011 ($MILLION)TABLE 112 COVIDIEN, PLC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)TABLE 113 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011($MILLION)TABLE 114 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011($MILLION)TABLE 115 JOHNSON AND JOHNSON: MEDICAL DEVICES AND DIAGNOSTICS REVENUE,BY DIVISIONS, 2009 – 2011 ($MILLION)TABLE 116 JOHNSON AND JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011
  • ($MILLION)TABLE 117 MERIT MEDICAL SYSTEMS, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 – 2011 ($MILLION)TABLE 118 MERIT MEDICAL SYSTEMS, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 201($MILLION)TABLE 119 MERIT MEDICAL SYSTEMS, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 –2011 ($MILLION)TABLE 120 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011($MILLION)TABLE 121 STRYKER CORPORATION: TOTAL REVENUES, BY SEGMENTS, 2009 – 2011($MILLION)TABLE 122 STRYKER CORPORATION: NEUROTECHNOLOGY AND SPINE SEGMENT TOTALREVENUE, 2009 – 2011 ($MILLION)TABLE 123 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011($MILLION)TABLE 124 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 –2012 ($MILLION)TABLE 125 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012($MILLION)TABLE 126 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012($MILLION)List Of FiguresFIGURE 1 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET REVENUE, 2012 & 2017FIGURE 2 NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2012FIGURE 3 NEUROINTERVENTIONAL DEVICES MARKET SEGMENTATIONFIGURE 4 MARKET DYNAMICSFIGURE 5 GLOBAL NEUROINTERVENTIONAL MARKET SHARE, BY PLAYERS, 2012FIGURE 6 NEUROTHROMBECTOMY DEVICES SEGMENTATIONFIGURE 7 NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT SEGMENTS,2012 & 2017FIGURE 8 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS SEGMENTATIONFIGURE 9 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION &FISTULA EMBOLIZATION DEVICES SEGMENTATIONFIGURE 10 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION &FISTULA EMBOLIZATION DEVICES MARKET SHARE, BY PRODUCT SEGMENTS, 2012 &2017FIGURE 11 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET SHARE, BY GROWTHSTRATEGIES, 2009 – 2012
  • Contact: sales@reportsandreports.com for more information.